Janney Montgomery Scott LLC Crispr Therapeutics Ag Transaction History

Janney Montgomery Scott LLC

  • $36.1 Billion
  • Q4 2024

A detailed history of Janney Montgomery Scott LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 6,876 shares of CRSP stock, worth $299,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,876
Previous 7,842 12.32%
Holding current value
$299,037
Previous $368,000 26.36%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
SELL
$38.65 - $55.15 $37,335 - $53,274
-966 Reduced 12.32%
6,876 $271,000
Q3 2024

Oct 29, 2024
SELL
$44.62 - $62.75 $123,642 - $173,880
-2,771 Reduced 26.11%
7,842 $368,000
Q2 2024

Jul 25, 2024
BUY
$51.17 - $68.18 $83,458 - $111,201
1,631 Added 18.16%
10,613 $573,000
Q1 2024

May 01, 2024
SELL
$60.67 - $89.12 $17,048 - $25,042
-281 Reduced 3.03%
8,982 $612,000
Q4 2023

Feb 07, 2024
SELL
$38.62 - $72.18 $147,682 - $276,016
-3,824 Reduced 29.22%
9,263 $580,000
Q3 2023

Nov 08, 2023
BUY
$45.39 - $59.0 $270,705 - $351,876
5,964 Added 83.73%
13,087 $594,000
Q2 2023

Jul 26, 2023
BUY
$43.47 - $67.77 $83,766 - $130,592
1,927 Added 37.09%
7,123 $400,000
Q1 2023

Apr 28, 2023
BUY
$41.0 - $56.12 $213,036 - $291,599
5,196 New
5,196 $235,000
Q3 2022

Oct 25, 2022
BUY
$61.1 - $83.78 $2,932 - $4,021
48 Added 0.45%
10,677 $698,000
Q2 2022

Aug 03, 2022
BUY
$43.23 - $73.83 $22,090 - $37,727
511 Added 5.05%
10,629 $673,000
Q1 2022

May 04, 2022
SELL
$53.19 - $79.24 $12,233 - $18,225
-230 Reduced 2.22%
10,118 $635,000
Q4 2021

Jan 27, 2022
SELL
$70.09 - $111.29 $484,602 - $769,459
-6,914 Reduced 40.05%
10,348 $784,000
Q3 2021

Oct 29, 2021
BUY
$110.2 - $156.64 $277,593 - $394,576
2,519 Added 17.09%
17,262 $1.93 Million
Q2 2021

Jul 26, 2021
BUY
$100.84 - $161.89 $112,739 - $180,993
1,118 Added 8.21%
14,743 $2.39 Million
Q1 2021

Apr 27, 2021
BUY
$110.72 - $210.04 $745,367 - $1.41 Million
6,732 Added 97.66%
13,625 $1.66 Million
Q4 2020

Jan 25, 2021
SELL
$79.67 - $173.23 $12,348 - $26,850
-155 Reduced 2.2%
6,893 $1.06 Million
Q3 2020

Nov 06, 2020
BUY
$78.5 - $100.64 $94,435 - $121,069
1,203 Added 20.58%
7,048 $589,000
Q2 2020

Jul 23, 2020
BUY
$38.5 - $76.05 $20,828 - $41,143
541 Added 10.2%
5,845 $430,000
Q1 2020

Apr 30, 2020
SELL
$33.68 - $62.53 $119,631 - $222,106
-3,552 Reduced 40.11%
5,304 $225,000
Q4 2019

Jan 21, 2020
BUY
$36.68 - $73.13 $141,804 - $282,720
3,866 Added 77.47%
8,856 $539,000
Q3 2019

Oct 29, 2019
BUY
$40.99 - $52.56 $204,540 - $262,274
4,990 New
4,990 $205,000

Others Institutions Holding CRSP

# of Institutions
488
Shares Held
60.3M
Call Options Held
1.26M
Put Options Held
1.81M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.39B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email